Advanced Medicine

How can you ensure your gene therapy research won’t be slowed down by synthesis problems?

Sitting Down With… Matthew Durdy, Chief Executive, Cell and Gene Therapy Catapult.

What lies ahead for the future of pharma? Dennis van Rooji gives his view.

Accelerating the progress of cell and gene therapies with decentralized trials and other innovative approaches.

Cell and Gene therapies have come a long way since the 1970s. Technology, combined with knowledge, will take them even further.

Jon Thomas, CEO of CIRM, discusses the evolution of stem cell research and the future of regenerative medicine in this interview.

We find out why Cas12l incorporated into a gene-writing system could help advance the field of gene editing.

Consider CIRM as a bank. We don’t conduct research ourselves: we fund it – and have become the largest dedicated funder of stem cell and gene therapy

We look back on a decade of breakthroughs in advanced medicine – explore our top articles on cell and gene therapy.

A look back at The Medicine Maker archive and the influence of science fiction in the industry and science.